Combination of BIBF 1120, BIBW 2992 and mFOLFOx7 as first-line therapy for colorectal cancer
Ontology highlight
ABSTRACT: Primary objectives: To compare efficacy and safety of mFOLFOX 7 plus weekly alternating administration of BIBW 2992 and BIBF 1120 versus mFOLFOX 7 in patients with metastatic colorectal cancer.
Primary endpoints: Objective response.
DISEASE(S): Metastatic Colorectal Cancer,Metastatic Colorectal Carcinoma
PROVIDER: 2520519 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA